Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression
出版年份 2017 全文链接
标题
Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression
作者
关键词
-
出版物
Cell Death & Disease
Volume 8, Issue 7, Pages e2944
出版商
Springer Nature
发表日期
2017-07-20
DOI
10.1038/cddis.2017.335
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer
- (2015) H. Takahashi et al. MOLECULAR CANCER THERAPEUTICS
- Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells
- (2015) Qinsheng Dai et al. MOLECULAR CARCINOGENESIS
- The Pro-Apoptotic Role of the Regulatory Feedback Loop between miR-124 and PKM1/HNF4α in Colorectal Cancer Cells
- (2014) Yan Sun et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
- (2014) Supriya K. Saha et al. NATURE
- Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents
- (2013) Chad Walesky et al. HEPATOLOGY
- Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells
- (2013) Qinsheng Dai et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Oroxylin A has therapeutic potential in acute myelogenous leukemia by dual effects targeting PPARγ and RXRα
- (2013) Hui Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Beclin 1-mediated autophagy in hepatocellular carcinoma cells: Implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling
- (2012) Meijuan Zou et al. CELLULAR SIGNALLING
- Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy
- (2012) Hidenori Toyoda et al. JOURNAL OF HEPATOLOGY
- Dual effects of sodium butyrate on hepatocellular carcinoma cells
- (2012) Wenjun Jiang et al. MOLECULAR BIOLOGY REPORTS
- Activation of the unfolded protein response contributed to the selective cytotoxicity of oroxylin A in human hepatocellular carcinoma HepG2 cells
- (2012) Min Xu et al. TOXICOLOGY LETTERS
- Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
- (2011) Digant Gupta et al. Nutrition Journal
- The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism
- (2010) C. V. Clower et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice
- (2009) Li Zhao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MAC related mitochondrial pathway in oroxylin A induces apoptosis in human hepatocellular carcinoma HepG2 cells
- (2009) Wei Liu et al. CANCER LETTERS
- Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies
- (2009) Puneeta Tandon et al. LIVER INTERNATIONAL
- HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
- (2009) Charles J. David et al. NATURE
- Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells
- (2009) S. Choi et al. XENOBIOTICA
- Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection
- (2008) Shu-Chun Chuang et al. CANCER LETTERS
- Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4α gene
- (2008) Chuan Yin et al. HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started